Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis?

Background/AimsNonselective β-blockers (NSBBs), such as propranolol, reportedly exert a pleiotropic effect in liver cirrhosis. A previous report suggested that survival was higher in patients receiving adjusted doses of NSBBs than in ligation patients. This study investigated whether low-dose NSBB m...

Descripció completa

Dades bibliogràfiques

Autors principals:	Tae Wan Kim, Hong Joo Kim, Chang Uk Chon, Hyun Sun Won, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim
Format:	Artigo
Idioma:	Inglês
Publicat:	Korean Association for the Study of the Liver 2012-06-01
Col·lecció:	Clinical and Molecular Hepatology
Matèries:	Nonselective β-blockers Liver cirrhosis Overall survival Child-Turcotte-Pugh
Accés en línia:	http://e-cmh.org/upload/pdf/cmh-18-203.pdf
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!